New Clinical Trials For Stage IV Breast Cancer
New clinical trials for stage 4 breast cancer are available. See clinical trials for HR-positive, HER2-negative, triple-negative, and other subtypes.
Read More
PAST ARTICLES
2022
- All About Vaccines for MBC
- How Trial Participation is Becoming Easier: Managing Finances, Travel, and Other Considerations
- Breast Cancer Liver Metastasis: Highlighting the Experts
- Updates from ASCO 2022
- What Are Crossover Trials and How Do They Work?
- Are You Hesitant to Participate in Trials Because of Data Privacy?
- Breast Cancer Bone Metastasis: Highlighting the Experts
- How Trial Participation Is Becoming Easier: Decentralization
- Updates from AACR 2022 Meeting
- FDA Expands Approval for Enhertu®
- Triple-Negative Metastatic Breast Cancer: Beyond ER, PR, and HER2
- Breast Cancer Brain Metastasis: Highlighting the Experts
- Patient Advocate Foundation – Our Newest Partner!
- Why Attend a Medical Conference?
- All About Phase IV Clinical Trials
- Update on Immunotherapy for MBC: Immune Checkpoint Inhibitors
- Updates from Miami Breast Cancer Conference 2022
- Why Do Some People Have an Exceptional Response When Being Treated for MBC?
- All About Phase III Clinical Trials
- What is Complementary and Integrative Medicine?
- Update On Antibody-Drug Conjugates (ADCs) For MBC
- All About Phase II Clinical Trials
- Why Does The Same Drug Work Differently In Different People?
- When We Tri(al)—Our New Partner!
- Virtual Conferences: How Do I Prepare?
- Mark Your 2022 Calendars!
- All About Phase I Clinical Trials
- Male MBC Treatment And Clinical Trials
- MBCBrainMets.org – Our New Partner!
- Bispecific Antibodies: An Emerging Class Of MBC Drugs
- COVID-19 Vaccine Doses for People with MBC
- MBC and NED
- “Standard of Care” for MBC
- Treatment for MBC While Pregnant
- MBC-Related News from SABCS
2021
- Advanced Breast Cancer Conference 2021
- Scan Anxiety
- Treatment Strategies for Triple-Positive MBC
- What do FGFR Genetic Mutations Mean for You and Your MBC?
- Understanding Informed Consent
- Cannabis Use For Managing Symptoms and Side Effects
- Metronomic Chemotherapy: Looking at A New Way to Receive Treatment
- Lobular Metastatic Breast Cancer
- Financial Toxicity: Managing Costs While Enrolled in a Clinical Trial
- What are Solid Tumor Trials and Why Are They Important?
- Prepare For SABCS 2021
- Inflammatory MBC Treatments
- Pink October/MBC Awareness Day
- Steps Toward Expanding Eligibility Criteria to Increase Diversity in Clinical Trials
- Metastatic Breast Cancer News from 2021 ESMO
- Theragnostics
- Spotlight on the Tigerlily Foundation & Breast Cancer Racial Disparities
- Health Insurance for MBC
- Atezolizumab Immunotherapy Is Withdrawn From FDA-Approval Process
- Metastatic Trial Search: New Features
- Metastatic Breast Cancer News from ASCO 2021
- FDA Fast Track
- Adoptive Cell Therapies for Metastatic Solid Cancers
- Black Breast Cancer & BRCA1/2 Mutations
- Immunotherapy Resistance
- Modernizing Clinical Trials
- Update on Oral SERDs for Estrogen Receptor-Positive MBC
- MBC News from 2021 AACR Meeting
- Videos About Breast Cancer Clinical Trials
- Lymphodepletion in Cancer Immunotherapy
- Where You Can Find Current MBC Research
- Local Therapies for Liver Mets
- Y-90 Internal Radiation Therapy for Liver Mets
- St. Gallen International Breast Cancer Conference 2021
- Spotlight on New Partners
- 2021 Miami Breast Cancer Conference
- Just-in-Time Trials
- Update on Hormone Receptor-Positive MBC
- Side Effects of Radiation Therapy for Brain Mets
- Other MBC Resources
- COVID-19 & Cancer: Getting the Vaccine
- Metastatic Breast Cancer in the LGBTQI Communities
- Expanded Access
- 2021 Update on Metastatic Triple Negative Breast Cancer Treatment
- Screening for Breast Cancer Brain Metastases
- COVID-19 & Cancer
- Participating in a Trial: Patient Voices
- FDA Approves MARGENZA™
- Treating Breast Cancer Brain Mets
- Circulating Tumor Cell Testing
- What is a Washout Period?
- Spotlight on MBC Podcasts
- What is Next-Generation Sequencing?
- Lines of Therapy: New Drugs May Change MBC Treatment
- What Are “Lines of Therapy”?
- Warmest Wishes for 2021
2020
- When to Use Surgery & Radiation to the Breast
- Metastatic Trial Search: New & Improved
- Body Image and Metastatic Breast Cancer
- COVID-19 & Cancer: Mental Health
- MBC & Parenting During COVID
- The Right Dose
- FDA Approves Keytruda®
- COVID-19 & Cancer: Financing Your Care
- Art Therapy for People with MBC
- HER2-Low Expressing: A New Subcategory of HER2-Negative Breast Cancer?
- How to Prepare for a Virtual SABCS
- COVID-19 & Cancer: COVID Vaccines
- MBC, Advanced Breast Cancer & Locally Advanced Breast Cancer: What’s in a Name?
- COVID-19 & Cancer: Alternative Ways to Get Care
- Living with Metastatic Breast Cancer During October
- Imaging Tests for People with Stage IV Breast Cancer
- The Impact of MBC on Work and Career
- PD-L1 Biomarker for Immunotherapy
- Depression & Metastatic Breast Cancer
- LBBC’s Conference on Metastatic Breast Cancer
- Metastatic Breast Cancer at a Young Age
- How Participants are Divided into Treatment Groups in Clinical Trials
- Sexual Side Effects of MBC Treatment
- What is ER-Low Breast Cancer?
- Clinical Trials Are Not Only a “Last Resort”
- Spotlight on Metastatic Breast Cancer in Older People
- FDA Approves PHESGO™
- HER2 Positive Metastatic Breast Cancer Research Update
- Peer Support for Metastatic Breast Cancer
- How to Find Metastatic Breast Cancer Clinical Trials
- Metastatic Breast Cancer News from ASCO 2020
- COVID-19 & Breast Cancer
- Clinical Trials Primer
- Telemedicine in Clinical Trials
- Recent FDA Approvals for Metastatic Breast Cancer
- ASCO, ESMO and More
- ASCO, ESMO and More
- What is a Patient Navigator?
- Find Trials That Are Right For You
- Managing Anxiety
- COVID-19 & Cancer: Financial Assistance
- COVID-19 & Cancer: Patient Advocacy
- COVID-19 & Cancer: Wellness & Resources
- COVID-19 & Cancer: Cancer Care
- COVID-19 & Cancer: Online Learning
- COVID-19 & Cancer: Clinical Trials During COVID-19
- COVID-19 & Cancer: MBC Trials From Home
- COVID-19 & Cancer: Personal Stories
- The Tumor Microenvironment
- Komen LA MBC Conference
- Black Women Facing Breast Cancer
- Do You Know Your Rights as a Cancer Patient?
- Pain Management
- What is Your Tumor’s Mutation Burden?
- Mark Your 2020 Calendars Now!
- MBC in the Transgender Community
- Commonly Used Terms in Clinical Trials
- Exercise and Stage 4 Breast Cancer
- How To Get a Newly Approved Cancer Drug
- Triple-Negative Breast Cancer Update
- True or False?
- New Features on MTS
- Cancer & PTSD
- Big Data & Cancer Research
2019
- Warmest Wishes
- Tips for Reading Cancer News
- What Do Drug Names Mean?
- When Cancer Meets Holiday Cheer
- Diagnosing & Treatment of Bone Metastases
- What is a Tumor Agnostic Therapy?
- 2019 ESMO: What We Learned About MBC
- True or False?
- Expanding Eligibility Criteria
- Dragon Boat Racing
- Genetic vs. Genomic Testing
- About MBC Awareness Day
- Treating Brain Metastases
- Catch Up on the NW MBC Conference
- OS vs. PFS: What You Need to Know
- How to Ask Your Doctor About Clinical Trials
- More Men Needed in Breast Cancer Trials
- New FDA Approval: A PI3K Inhibitor
- 2019 ASCO: What We Learned About MBC
- True or False?
- New Guideline Includes Immunotherapy
- How to Get a Medical Interpreter
- Should You Get A Second Opinion?
- One Year Anniversary Issue
- Best of MBC Research News (2018-2019)
- Best of Inside Clinical Trials (2018-2019)
- Best of Resources & Support (2018-2019)
- Best of From the Experts (2018-2019)
- Best of Personal Stories (2018-2019)
- What is Oligometastatic Breast Cancer?
- View Presentations from Komen’s Regional Conferences
- Doctors & Patients on Clinical Trials
- Genomic Testing: What Makes Your Tumor Grow?
- MBC Facebook Groups
- Treatment Guidelines for Metastatic Breast Cancer
- ASCO is Here! Follow Along in Real Time
- Metastatic Breast Cancer Blogs
- Why the Phase of a Clinical Trial Matters
- Planning Ahead: Advance Care Plans
- The Future of Metastatic Breast Cancer Treatment
- First Immunotherapy Approved for MBC
- Video Portraits of MBC
- Patient-Reported Outcomes in Clinical Trials
- Coordinating Support for You and Your Family
- Palliative Care
- Liquid Biopsies: More than a Blood Test?
- Miami Breast Cancer Conference
- From Down Under: Stories of MBC
- What Are Master Protocols?
- ¿Hablas Español?
- Learn From Home With a Webinar
- Get the Latest News on PARP Inhibitors
- Life with MBC: 10+ Years and Counting
- All about Basket and Umbrella Trials
- Consider a Retreat
- What is CAR-T Therapy?
- New Research Presented at San Antonio
- Highlights from San Antonio
- Patient and Advocate Perspectives on San Antonio
- Support for MBC Caregivers
- Managing Lymphedema
2018
- Reporting Side Effects in Cancer Clinical Trials
- Stories of De Novo Breast Cancer
- How to Find Results from Clinical Trials
- Evidence-Based Information on Herbs and Supplements
- Your Tumor and Experience Could Lead to New Treatments
- Thriving at a Cancer Conference
- MBC Patients in The News
- Talking to Kids About MBC
- Biosimilar Drugs & Breast Cancer
- Immunotherapy & Metastatic Breast Cancer
- Watch Meetings From Across the U.S.
- Living with Triple Negative MBC
- The Lack of Diversity in Clinical Trials
- Where to Find Financial Support
- Bone Only Mets & Measurable Lesions
- Insights into Treatment Resistance
- Speaking Out on Inflammatory Breast Cancer
- Perspectives on Clinical Trials
- Living with MBC
- Managing Pain and Side Effects
- Update on CDK Inhibitors
- Cancer Moonshot & Metastases
- Voices of Men with MBC
- Finding Support Groups
- CRISPR & Cancer
- Treating BRCA1/2 Metastatic Breast Cancer
- News From ASCO 2018
- Metastatic Breast Cancer Advocacy
- Clinical Trials: Who Gets to Take Part?
- Share Links, Give Feedback, Tell Us Your Story
- Looking for a Helpline?
- Chemo, Second Opinions & Disability Insurance
SEARCH OUR SITE
for past articles or specific information.